Work

Neoadjuvant Concurrent Chemoradiation and Esophagectomy for Esophageal Cancer: Outcomes With New‐Onset Atrial Fibrillation

Year: 2025

Type: article

Abstract: This illustrates the outcomes of patients with esophageal cancer undergoing neoadjuvant concurrent chemoradiation and esophagectomy, specifically focusing on those who develop new-onset atrial fibrillation (NOAF). Statistically significant findings (p < 0.05, dark red) increased mortality and ventricular fibrillation, as well as trends of (p > 0.05, light red) myocardial infarction and pericardial effusion among NOAF patients. The data emphasize the significant cardiovascular risks associated with NOAF in this population.

Source: Thoracic Cancer

DOI: 10.1111/1759-7714.15518

Authors: Stefano H. Byer, Aravinthasamy Sivamurugan, Udhayvir S. Grewal

Institutions: University of Iowa Hospitals and Clinics, University of Iowa

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,030